Tonix TNX-102 SL: Innovating Fibromyalgia Treatment in Development
In this interview, we sit with Seth Lederman, CEO of Tonix Pharmaceuticals, about their new drug in development for...
Breakthroughs in Post-Polio Syndrome Treatment: Grifols’ Innovative Approach
In this discussion, Dr. Jörg Schüttrumpf, Chief Scientific Innovation Officer at Grifols, delves into the promising results of their...
Durect Transforming AH Treatment with Larsucosterol’s Promise
In this interview, Jim Brown, CEO of Durect Corporation, shared insights into the treatment of Alcohol-Associated Hepatitis (AH) with...
Promising Interim Results from Phase III Agalsidase Beta Study for Fabry Disease
Biosidus, an Argentinian biotechnology company, announced positive interim Phase III trial results for its agalsidase beta biosimilar for Fabry...
Sabin Launches Marburg Vaccine Trial in US
The Sabin Vaccine Institute initiated a Phase 2 clinical trial of its Marburg vaccine candidate in the United States,...
Sonnet Releases Positive Safety Data for SON-1010 in Phase 1b/2a
Sonnet BioTherapeutics announced positive safety data for SON-1010 (IL12-FHAB) at the highest dose combined with atezolizumab in a Phase...
BioVie Starts Bezisterim SUNRISE-PD Trial in Early Parkinson’s
BioVie Inc. has initiated patient enrollment for its Phase 2 SUNRISE-PD clinical trial. This trial investigates the safety and...
Briacell Phase 2 Data: HR+ Breast Cancer Breakthrough
BriaCell Therapeutics Corp. announced positive survival data from its Phase 2 study of Bria-IMT™ combined with checkpoint inhibitors in...
Cln-978: Groundbreaking RA Therapy Enters Phase 1 Trial
Cullinan Therapeutics announced that the European Medicines Agency (EMA) approved its Clinical Trial Application for CLN-978, a novel CD19xCD3...
Macro Trends in Pharma: AI, Innovation, and the Impact on Outsourcing Strategy
At SCOPE Summit 2025, a panel discussion explored the industry’s macro trends, focusing on AI, innovation, and outsourcing strategies....